The store will not work correctly when cookies are disabled.
Azepane-1-carbothioic acid (1-pyrimidin-4-yl-ethylidene)-hydrazide
ID: ALA112791
PubChem CID: 9579567
Max Phase: Preclinical
Molecular Formula: C13H19N5S
Molecular Weight: 277.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C/C(=N\N=C(/S)N1CCCCCC1)c1ccncn1
Standard InChI: InChI=1S/C13H19N5S/c1-11(12-6-7-14-10-15-12)16-17-13(19)18-8-4-2-3-5-9-18/h6-7,10H,2-5,8-9H2,1H3,(H,17,19)/b16-11+
Standard InChI Key: PQSAZDRXJQKRLZ-LFIBNONCSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
1.9500 -1.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4667 -1.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9125 -1.4792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4292 -1.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9042 -0.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9500 -0.8792 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.3875 -0.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 -0.8792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6500 0.0208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6500 -0.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3875 0.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3917 -2.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9000 -1.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 0.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4292 -0.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4875 -1.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7167 -2.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3292 -2.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6875 -2.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 4 1 0
4 1 2 0
5 3 2 0
6 1 1 0
7 5 1 0
8 7 2 0
9 14 1 0
10 8 1 0
11 7 1 0
12 2 1 0
13 2 1 0
14 11 2 0
15 5 1 0
16 13 1 0
17 12 1 0
18 17 1 0
19 16 1 0
19 18 1 0
10 9 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 277.40 | Molecular Weight (Monoisotopic): 277.1361 | AlogP: 2.36 | #Rotatable Bonds: 2 |
Polar Surface Area: 53.74 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.71 | CX Basic pKa: 3.23 | CX LogP: 1.91 | CX LogD: 1.27 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.39 | Np Likeness Score: -1.01 |
References
1. Easmon J, Heinisch G, Holzer W, Rosenwirth B.. (1992) Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents., 35 (17): [PMID:1354751] [10.1021/jm00095a027] |